News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

$12.8 Million Settlement Pending In KV Pharmaceutical Class-Action Suit


3/6/2014 7:57:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The bankrupt KV Pharmaceutical Co. has agreed to a pay a proposed $12.8 million to settle a class-action lawsuit. The settlement with lead plaintiffs Norfolk County Retirement System and the State-Boston Retirement System received preliminary approval in January from Judge Carol Jackson of the U.S. District Court for the Eastern District of Missouri. A settlement hearing is scheduled for April 23. The lawsuit alleges that KV made misstatements and omissions regarding its compliance with the FDA and with good manufacturing practices, according to a statement from Labaton Sucharow, the New York law firm representing the plaintiffs.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES